• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Microbot Medical Inc (NQ: MBOT )

    0.9011 +0.0009 (+0.10%)
    Streaming Delayed Price Updated: 3:56 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 56,528
    Open 0.9077
    Bid (Size) 0.9010 (6)
    Ask (Size) 0.9091 (18)
    Prev. Close 0.9002
    Today's Range 0.9000 - 0.9100
    52wk Range 0.8200 - 2.350
    Shares Outstanding 16,504,433
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
    Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024 
    From Microbot Medical Inc.
    Via GlobeNewswire

    Performance

    YTD
    -32.25%
    -32.25%
    1 Month
    +9.04%
    +9.04%
    3 Month
    -15.39%
    -15.39%
    6 Month
    -26.74%
    -26.74%
    1 Year
    -33.74%
    -33.74%

    More News

    Read More
    Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
    From Microbot Medical Inc.
    Via GlobeNewswire
    MBOT Stock Earnings: Microbot Medical Meets EPS for Q2 2024
    Via InvestorPlace
    Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
    From Microbot Medical Inc.
    Via GlobeNewswire
    Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Dow Dips Over 300 Points; GameStop Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
    From Microbot Medical Inc.
    Via GlobeNewswire
    Crude Oil Down Over 3%; US Construction Spending Falls In May
    Via Benzinga
    Exposures Fossil Fuels
    Why Microbot Medical Stock Is Up
    Via Benzinga
    Exposures Product Safety
    Nasdaq Surges 150 Points; US Manufacturing PMI Rises In May
    Via Benzinga
    Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
    From Microbot Medical Inc.
    Via GlobeNewswire
    MBOT Stock Earnings: Microbot Medical Meets EPS for Q1 2024
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.